Medical devices, healthcare technology and the business of care
510(k) clearance · K262147

CINA-Aneurysm+

AVICENNA.AI · Decision date Oct 19, 2026

MEDTECHLEDGER EXPLANATIONK262147

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for CINA-Aneurysm+ under 510(k) number K262147, with a decision date of 2026-10-19 and a receipt date of 06/25/2026. The applicant is Avicenna.Ai of La Ciotat, France. The device falls under regulation 892.2050, classification product code QIH, in the Radiology specialty and review panel. SESE in the 510(k) pathway denotes clearance for marketing, not premarket approval.

The submission is recorded as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The public record does not describe the device's components, intended use, or the specific predicate it was compared against; those details would sit in the linked summary document, which was not available in the source text. No clinical performance or labeling conclusions are drawn here.

The page lists a last-updated date of 11/09/2026, which is metadata about the database entry rather than a regulatory action date.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 19, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262147
Regulatory pathway
510(k) premarket notification
Applicant
AVICENNA.AI
Product code
QIH
Decision code
SESE
Decision date
Oct 19, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated Radiological Image Processing Software.

Applicant
Avicenna.AI
Product code
QIH
FDA device class
2

FDA decision timeline

  1. K262147 received

    Application receipt date recorded by FDA.

  2. K262147 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QIH

Product / regulatory recordCompanyPathwayDecision dateSource
Clever OneK260372
Ewoosoft Co., Ltd.510(k) clearanceNov 4, 2026FDA
Peek Health, S.A.510(k) clearanceNov 4, 2026FDA
UAB Ligence510(k) clearanceOct 7, 2026FDA
NeuroDRK262134
Deep Reasoning Ai, Inc.510(k) clearanceOct 7, 2026FDA
Medis Medical Imaging Systems BV510(k) clearanceOct 5, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Avicenna.AI

Headquarters
Not reported
Brand website
avicenna.ai
FDA applicant address
La Ciotat

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records